Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers
PHASE1
This is a randomized, active-controlled, dose-escalation multi-center study...
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
PHASE1
Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Status
Completed
Location
Walter Reed Army Institute of Research - Clinical Trials Center